Key result
Cell type-specific deletion of PAR1 in either cardiac myocytes or cardiac fibroblasts significantly increased Coxsackievirus B3 genomes, inflammatory infiltrates, and myocarditis compared to wild-type controls.
Why the study?
Mice with global PAR1 deficiency showed increased CVB3-induced myocarditis, prompting investigation into the cell type-specific effects of PAR1 deletion in cardiac myocytes and cardiac fibroblasts.
Answers are grounded in this paper and cite their sources.
PAR1 on cardiac fibroblasts protects against CVB3-induced myocarditis by enhancing the anti-viral response, whereas PAR1 on both cardiac myocytes and fibroblasts inhibits viral replication by reducing autophagy.
Protease-activated receptor 1 (PAR1) is widely expressed in humans and mice, and is activated by a variety of proteases, including thrombin. Recently, we showed that PAR1 contributes to the innate immune response to viral infection. Mice with a global deficiency of PAR1 expressed lower levels of CXCL10 and had increased Coxsackievirus B3 (CVB3)-induced myocarditis compared with control mice. In this study, we determined the effect of cell type-specific deletion of PAR1 in cardiac myocytes (CMs) and cardiac fibroblasts (CFs) on CVB3-induced myocarditis. Mice lacking PAR1 in either CMs or CFs exhibited increased CVB3 genomes, inflammatory infiltrates, macrophages and inflammatory mediators in the heart and increased CVB3-induced myocarditis compared with wild-type controls. Interestingly, PAR1 enhanced poly I:C induction of CXCL10 in rat CFs but not in rat neonatal CMs. Importantly, activation of PAR1 reduced CVB3 replication in murine embryonic fibroblasts and murine embryonic cardiac myocytes. In addition, we showed that PAR1 reduced autophagy in murine embryonic fibroblasts and rat H9c2 cells, which may explain how PAR1 reduces CVB3 replication. These data suggest that PAR1 on CFs protects against CVB3-induced myocarditis by enhancing the anti-viral response whereas PAR1 on both CMs and fibroblasts inhibits viral replication.
No takes yet. Share an insight, caveat, or question.
Bode et al. (2021) studied Coxsackievirus B3-induced myocarditis. Cell type-specific deletion of PAR1 vs. Wild-type controls was evaluated on CVB3 genomes, inflammatory infiltrates, and inflammatory mediators in the heart (p=<0.05). Cell type-specific deletion of PAR1 in either cardiac myocytes or cardiac fibroblasts significantly increased Coxsackievirus B3 genomes, inflammatory infiltrates, and myocarditis compared to wild-type controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: